vs
FS Bancorp, Inc.（FSBW）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是FS Bancorp, Inc.的1.7倍（$69.8M vs $40.0M），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 12.0%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 6.2%）
FS Bancorp, Inc.是总部位于美国的银行控股公司，为华盛顿第一安全银行的母公司，主要面向美国太平洋西北地区客户提供各类个人及商业银行服务，包括存款产品、住房贷款、小微企业融资、建筑贷款等，核心业务涵盖零售银行、商业银行及住房信贷三大板块。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
FSBW vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.7倍
$40.0M
营收增速更快
RIGL
高出9.2%
12.0%
两年增速更快
RIGL
近两年复合增速
6.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $40.0M | $69.8M |
| 净利润 | — | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 25.8% | 33.2% |
| 净利率 | — | 384.0% |
| 营收同比 | 12.0% | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $1.11 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FSBWRIGL
| Q4 25 | $40.0M | $69.8M | ||
| Q3 25 | $39.3M | $69.5M | ||
| Q2 25 | $37.3M | $101.7M | ||
| Q1 25 | $36.1M | $53.3M | ||
| Q4 24 | $35.7M | $57.6M | ||
| Q3 24 | $37.2M | $55.3M | ||
| Q2 24 | $36.3M | $36.8M | ||
| Q1 24 | $35.5M | $29.5M |
净利润FSBWRIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $9.2M | $27.9M | ||
| Q2 25 | $7.7M | $59.6M | ||
| Q1 25 | $8.0M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $10.3M | $12.4M | ||
| Q2 24 | $9.0M | $-1.0M | ||
| Q1 24 | $8.4M | $-8.2M |
毛利率FSBWRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率FSBWRIGL
| Q4 25 | 25.8% | 33.2% | ||
| Q3 25 | 29.5% | 40.9% | ||
| Q2 25 | 26.2% | 60.1% | ||
| Q1 25 | 26.2% | 23.9% | ||
| Q4 24 | 27.6% | 28.9% | ||
| Q3 24 | 26.5% | 25.4% | ||
| Q2 24 | 31.3% | 1.2% | ||
| Q1 24 | 29.7% | -23.6% |
净利率FSBWRIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | 23.4% | 40.2% | ||
| Q2 25 | 20.7% | 58.6% | ||
| Q1 25 | 22.2% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | 27.6% | 22.5% | ||
| Q2 24 | 24.7% | -2.8% | ||
| Q1 24 | 23.7% | -27.9% |
每股收益（稀释后）FSBWRIGL
| Q4 25 | $1.11 | $14.11 | ||
| Q3 25 | $1.18 | $1.46 | ||
| Q2 25 | $0.99 | $3.28 | ||
| Q1 25 | $1.01 | $0.63 | ||
| Q4 24 | $0.88 | $0.82 | ||
| Q3 24 | $1.29 | $0.70 | ||
| Q2 24 | $1.13 | $-0.06 | ||
| Q1 24 | $1.06 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $28.2M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $307.7M | $391.5M |
| 总资产 | $3.2B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资FSBWRIGL
| Q4 25 | $28.2M | $155.0M | ||
| Q3 25 | $61.3M | $137.1M | ||
| Q2 25 | $33.2M | $108.4M | ||
| Q1 25 | $62.7M | $77.1M | ||
| Q4 24 | $31.6M | $77.3M | ||
| Q3 24 | $40.3M | $61.1M | ||
| Q2 24 | $33.0M | $49.1M | ||
| Q1 24 | $45.4M | $49.5M |
总债务FSBWRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益FSBWRIGL
| Q4 25 | $307.7M | $391.5M | ||
| Q3 25 | $300.5M | $117.6M | ||
| Q2 25 | $297.2M | $81.9M | ||
| Q1 25 | $298.8M | $18.6M | ||
| Q4 24 | $295.8M | $3.3M | ||
| Q3 24 | $288.9M | $-14.6M | ||
| Q2 24 | $284.0M | $-29.9M | ||
| Q1 24 | $277.9M | $-31.7M |
总资产FSBWRIGL
| Q4 25 | $3.2B | $513.6M | ||
| Q3 25 | $3.2B | $242.5M | ||
| Q2 25 | $3.2B | $206.7M | ||
| Q1 25 | $3.1B | $176.0M | ||
| Q4 24 | $3.0B | $164.0M | ||
| Q3 24 | $3.0B | $139.4M | ||
| Q2 24 | $2.9B | $128.4M | ||
| Q1 24 | $3.0B | $126.5M |
负债/权益比FSBWRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $72.3M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $51.9M | — |
| 自由现金流率自由现金流/营收 | 129.8% | — |
| 资本支出强度资本支出/营收 | 50.9% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $107.2M | — |
8季度趋势，按日历期对齐
经营现金流FSBWRIGL
| Q4 25 | $72.3M | $22.0M | ||
| Q3 25 | $44.6M | $24.0M | ||
| Q2 25 | $7.1M | $30.5M | ||
| Q1 25 | $8.2M | $-893.0K | ||
| Q4 24 | $50.8M | $14.5M | ||
| Q3 24 | $-891.0K | $21.7M | ||
| Q2 24 | $9.9M | $302.0K | ||
| Q1 24 | $275.0K | $-5.0M |
自由现金流FSBWRIGL
| Q4 25 | $51.9M | — | ||
| Q3 25 | $41.6M | — | ||
| Q2 25 | $5.9M | — | ||
| Q1 25 | $7.8M | — | ||
| Q4 24 | $49.2M | — | ||
| Q3 24 | $-1.5M | — | ||
| Q2 24 | $9.6M | — | ||
| Q1 24 | $-82.0K | — |
自由现金流率FSBWRIGL
| Q4 25 | 129.8% | — | ||
| Q3 25 | 105.9% | — | ||
| Q2 25 | 15.7% | — | ||
| Q1 25 | 21.7% | — | ||
| Q4 24 | 137.7% | — | ||
| Q3 24 | -4.1% | — | ||
| Q2 24 | 26.6% | — | ||
| Q1 24 | -0.2% | — |
资本支出强度FSBWRIGL
| Q4 25 | 50.9% | — | ||
| Q3 25 | 7.7% | — | ||
| Q2 25 | 3.5% | — | ||
| Q1 25 | 1.0% | — | ||
| Q4 24 | 4.6% | — | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 0.8% | — | ||
| Q1 24 | 1.0% | — |
现金转化率FSBWRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 4.86× | 0.86× | ||
| Q2 25 | 0.92× | 0.51× | ||
| Q1 25 | 1.02× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | -0.09× | 1.75× | ||
| Q2 24 | 1.11× | — | ||
| Q1 24 | 0.03× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
